Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and ...
ImagineAR Inc. (CSE: IP) (OTCQB: IPNFF), is announcing that it has filed a lawsuit against Niantic, Inc. (Niantic) in the United States ...
21m
ImagineAR Inc. (CSE: IP) (OTCQB: IPNFF), is announcing that it has filed a lawsuit against Niantic, Inc. (Niantic) in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback